Clinical Report: HHS Notifies Covered Entities of Limited Reversal of 2024 ACA Nondiscrimination Final Rule

Overview

Revise to include the potential impact on transgender individuals' access to care.

Background

The enforcement of nondiscrimination provisions under the Affordable Care Act is critical for ensuring equitable access to healthcare for all individuals, particularly marginalized groups. The recent ruling in Tennessee v. Kennedy has significant implications for how gender identity is treated under federal law, potentially affecting access to care for transgender individuals. Understanding these changes is essential for healthcare providers to navigate compliance and uphold civil rights in their practices.

Data Highlights

No numerical data or trial data is presented in the article.

Key Findings

• The U.S. District Court for the Southern District of Mississippi vacated gender identity provisions of the 2024 ACA Nondiscrimination Rule.
• HHS will not enforce compliance with the vacated provisions related to gender identity discrimination.
• Protections against discrimination based on race, color, national origin, age, disability, and aspects of sex discrimination not impacted by the court's order will continue to be enforced.
• OCR is taking administrative steps to align internal guidance with the court's ruling.
• Individuals can still file complaints regarding discrimination based on other protected categories.

Clinical Implications

Healthcare providers must remain aware of the limitations imposed by the recent court ruling while continuing to uphold protections against other forms of discrimination. It is crucial to stay informed about both federal and state laws regarding nondiscrimination to ensure compliance and provide equitable care.

Conclusion

The recent court ruling necessitates a reevaluation of compliance strategies for healthcare entities regarding gender identity discrimination. Continued vigilance is required to protect the rights of all patients under the remaining nondiscrimination provisions.

Related Resources & Content

1. U.S. Department of Health and Human Services, HHS Office for Civil Rights, 2026 -- HHS Notifies Covered Entities of Limited Reversal of 2024 ACA Nondiscrimination Final Rule
2. The ASCO Post — Biden Administration Reverses Rule Limiting Access to Equitable Cancer Care for Sexual and Gender Minority Community
3. ada news — CMS proposes reversal of adult dental essential health benefit policy in payment notice 
4. ADA News — New federal rules on nondiscrimination in health care
5. Biden Administration Reverses Rule Limiting Access to Equitable Cancer Care for Sexual and Gender Minority Community
6. CMS proposes reversal of adult dental essential health benefit policy in payment notice
7. New federal rules on nondiscrimination in health care
8. Memorandum Opinion and Order Granting Plaintiffs’ Motion for Summary Judgment and Denying Defendants’ Cross-Motion to Dismiss
9. Nondiscrimination Policy Update | Medicaid
10. Supreme Court upholds Tennessee law restricting gender-affirming care for transgender minors - CBS News
11. 37522 Federal Register / Vol. 89, No. 88 / Monday
12. Gender Dysphoria/Gender Incongruence Guideline Resources | Endocrine Society
13. AAP: Proposed restrictions to gender-affirming care are a ‘baseless intrusion into the patient-physician relationship’ | AAP News | American Academy of Pediatrics
14. AAMC Joins Amicus Brief Opposing ND Ban on Gender-Affirming Care for Minors | AAMC
15. Haute Autorité de Santé - Care for transgender adults
16. HHS Releases Comprehensive Review of Medical Interventions for Children and Adolescents with Gender Dysphoria | HHS.gov
17. Puberty blockers for gender dysphoria in youth: A systematic review and meta-analysis - PMC
18. Frontiers | Use of gonadotropin-releasing hormone agonists in transgender and gender diverse youth: a systematic review
19. Provision of gender-affirming care for trans and gender-diverse adults: a systematic review of health and quality of life outcomes, values and preferences, and costs - PMC
20. Gender-Affirming Hormone Therapy and Depression in Transgender Adults
21. Emotional Health of Transgender Youth 24 Months After Initiating Gender-Affirming Hormone Therapy - PubMed
22. Gender-affirming hormone therapy: effects on cardiovascular risk and vascular function - PubMed
23. Transgender persons receiving gender-affirming hormone therapy: risk of acute cardiovascular events in a Dutch cohort study - PubMed
24. Puberty blockers: UK trials to determine whether drugs benefit trans adolescents will go ahead | The BMJ